F. Lamoth

Discipline

Sociologie (3) Sciences de l'information et de la communication (2) Economies et finances (2) Psychologie (1) Gestion et management (1)

Type de document

Articles (51) Recensions (10) Mémoires, Thèses et HDR (1)

Co-auteur

Date

Source

Mot-clé

Treatment (31) thérapie (25) Therapeutics (25) Human beings (25) Patients (24) Patients (23) Infection (19) infection (17) Use (15) Aspergillosis (14) espèce (13) Species (13) Diagnosis (12) Diagnosis (12) Infections (12) résistance (12) Management (11) Susceptibility (11) Cases (10) Aspergillus (10) Cases (10) gestion (9) Aspergillus fumigatus (9) Candida (9) Blood (9) Management (9) Analysis (9) puits (8) mortalité (8) analyse (8)

Documents écrit par F. Lamoth (52) | parle de F. Lamoth (0)

Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician.
F. Lamoth (2023)
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
M. Papadimitriou-Olivgeris et al.
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
T. Born et al.
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
A. Kritikos et al. (18 mai 2022)
Tularémie pulmonaire : un diagnostic à ne pas manquer [Pulmonary tularemia : a diagnosis not to be missed]
P. Uriel Valladares et al. (13 avr. 2022)
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
R.S. Roth et al.
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.
S. Ragozzino et al.
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
N. Pellaton et al. (2022)
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
J. Li et al. (22 déc. 2021)
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
J. Battistolo et al.
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.
K.M. Adam et al.
Pancreatitis, hypereosinophilia and bilateral pulmonary infiltrates as presentation of acute Q fever.
A. Cancela Costa et al.
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
S. Meylan et al. (5 juil. 2021)
Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections.
G. Caudron de Coquereaumont et al.
Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.
J. Tschopp et al.
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
D. Neofytos et al. (24 mars 2021)
Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".
A. Kritikos et al. (9 févr. 2021)
Invasive Pulmonary Aspergillosis Goes Viral Again?
J. Wauters et al. (1 févr. 2021)
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.
J.J. Vehreschild et al. (4 janv. 2021)
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
J. Lourenco et al. (2021)
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
P. Filippidis et al. (2021)
Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.
F. Lamoth et al. (30 déc. 2020)
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
F. Lamoth et al.
Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
L.A. Decosterd et al. (10 nov. 2020)
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
A. Othenin-Girard et al. (2 nov. 2020)

next